Organization
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
1 clinical trial
Clinical trial
A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to ImmunotherapyStatus: Not yet recruiting, Estimated PCD: 2028-07-01